The Ozempic lawsuit, filed against pharmaceutical giants Novo Nordisk and Eli Lilly, alleged that the drugs, both Glucagon-like peptide 1 (GLP-1) agonists, caused severe gastrointestinal issues.
Here are a few noteworthy long-term risks associated with Ozempic overdose: 1
Tirzepatide, on the other hand, is an overachiever
For example, in a study where obese volunteers had unlimited access ( ad libitum ) to three meals (lunch, dinner and snacks), it was observed that treatment with semaglutide (1 mg/wk) caused a 24% decrease in energy intake during the day, leading to a reduction in body weight of approximately 5 kg after 12 weeks of treatment
When we discuss semaglutide for weight loss side effects , were often talking about the bodys natural reaction to a significant metabolic shift